Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Exiqon As (EXQNF)

Exiqon As (EXQNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Exiqon As

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Exiqon A/S is a custom treatment provider for cancer patients. The company is divided into three operating segments: Diagnostics, Pharma Services, and Life Sciences. The company's Diagnostics segment offers tests that better aid treatment courses for physicians to choose. Oncotech EDR Assays is a cellular diagnostic test that measures drug resistances. The results of the tests state whether a patient would be resistant to or a good candidate for certain chemotherapies. The product line addresses testing for lung, colorectal, ovarian, and endometrial cancers. One a diagnosis is made, a specific in vitro therapy is given. The Phrama Services maintains a catalogue of over 150,000 human tumors that it conducts research on with pharmaceutical company partnerships. The company uses its faculties to determine drug resistance and aptitude in treating certain cancers. The Pharma segment also offers diagnostic services. The Life Sciences segment offers products for the analysis of microRNA molecules. These products reveal genetic profiles to researches. The company sells to the pharmaceutical, diagnostic, and technology industries. It also serves biological academic and research institutions. Its product portfolio comprises of microRNA Research, RNA Research, DNA Research, Custom Oligos, and Other Reagents.

Key Statistics

Overview:

Annual Net Income, $ 0 K
3-Year Return 0.00%
5-Year Return 0.00%

Per-Share Information:

Next Earnings Date N/A
Dividend Payout Ratio 0.00%

EXQNF Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow 81.16
Price/Book 3.37
Book Value/Share N/A
Interest Coverage N/A
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar